Compare
Mangoceuticals, Inc. vs BioRestorative Therapies, Inc. vs Charming Medical Ltd vs Pacific Health Care Organization Inc
| Latest fiscal year | Mangoceuticals, Inc. MGRX | BioRestorative Therapies, Inc. BRTX | Charming Medical Ltd MCTA | Pacific Health Care Organization Inc PFHO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-03-31 | 2025-12-31 |
| Revenue | $456.0K | $359.7K | $4.81M | $6.72M |
| Revenue growth (YoY) | -26.0% | -10.3% | -22.7% | +10.7% |
| Gross margin | 54.9% | 93.4% | n/a | n/a |
| Operating margin | n/m | n/m | -0.6% | 14.9% |
| Net margin | n/m | n/m | -0.5% | 20.7% |
| Net income | -$20.64M | -$14.24M | -$22.6K | $1.39M |
| EPS (Diluted) | -$2.17 | -$1.58 | $0.00 | $0.11 |
| Operating cash flow | -$5.85M | -$10.79M | -$1.22M | $1.16M |
| Free cash flow | n/a | -$10.91M | -$1.56M | $1.14M |
| Cash & equivalents | $1.49M | $1.51M | $4.70M | $2.17M |
| Total assets | $16.09M | $4.08M | $9.87M | $13.46M |
| Total liabilities | $890.6K | n/a | $4.69M | n/a |
| Shareholders' equity | $15.20M | $356.7K | $5.18M | $13.07M |
| Return on year-end equity | -135.8% | n/m | -0.4% | 10.6% |
| Shares outstanding | 15.89M | 8.88M | n/a | 12.80M |
Revenue, most recent five fiscal years
| Fiscal year | Mangoceuticals, Inc. | BioRestorative Therapies, Inc. | Charming Medical Ltd | Pacific Health Care Organization Inc |
|---|---|---|---|---|
| Latest | $456.0K Ended 2025-12-31 | $359.7K Ended 2025-12-31 | $4.81M Ended 2026-03-31 | $6.72M Ended 2025-12-31 |
| 1 year earlier | $615.9K Ended 2024-12-31 | $401.0K Ended 2024-12-31 | $6.22M Ended 2025-03-31 | $6.07M Ended 2024-12-31 |
| 2 years earlier | $731.5K Ended 2023-12-31 | $145.8K Ended 2023-12-31 | $6.02M Ended 2024-03-31 | $5.63M Ended 2023-12-31 |
| 3 years earlier | $8.9K Ended 2022-12-31 | $119.8K Ended 2022-12-31 | n/a | $5.74M Ended 2022-12-31 |
| 4 years earlier | n/a | $46.0K Ended 2021-12-31 | n/a | $5.40M Ended 2021-12-31 |